Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing non-antibiotic, oral solutions for the prevention and control of gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see http://www.anataralifesciences.com for further background.

     

News

FINANCE VIDEO: Anatara Lifesciences Ltd (ASX:ANR) Gold Coast Investment Showcase Investor Presentation

🕔6/21/2017 2:07:56 PM 2490

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation for the Gold Coast Investment Showcase (June 21st & 22nd 2017).

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Wilsons Equity Research Report Issued with Buy Rating

🕔6/8/2017 10:30:52 AM 1473

Wilsons maintain a BUY rating and $1.66 price target. Anatara's recent stock underperformance has simply reflected a slow quarter for news in the lead-up to a significant inflection point in the 2H.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Update and R&D Tax Rebate

🕔6/6/2017 8:24:57 AM 1667

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide investors with an update on recent progress.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) ABC Video Program - Non-Antibiotic Treatment for Pigs

🕔3/23/2017 6:45:01 PM 2351

An oral drench to protect piglets from gut infection could soon be available to pig farmers. It's been developed by scientists and is made from pineapples - taking antibiotics out of the food chain.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report and Accounts

🕔2/23/2017 9:20:20 AM 2015

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the Company's Half Yearly Report for the period ended 31 December, 2016.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives Second Payment for Detach Under The Agreement with Zoetis (NYSE:ZTS)

🕔1/30/2017 10:20:19 AM 2739

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that it has received a second payment under the exclusive Evaluation and License Option Agreement with the leading global animal health company Zoetis Inc. (NYSE:ZTS) for Detach(TM), Anatara's non-antibiotic anti-infective product.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Research Report 'A Good Gut Feeling' by NDF Research

🕔1/25/2017 10:24:29 AM 2358

NDF Research yesterday released its initiation report on Anatara Lifesciences Ltd (ASX:ANR). The report provided a valuation at $2.22 per share base case and $5.94 per share optimistic case using a DCF approach, with a target price of $4.00 per share sitting midpoint of their valuation range.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Update

🕔11/22/2016 8:27:13 AM 1922

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its updated investor presentation.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) AGM Presentation

🕔11/15/2016 11:51:40 AM 1818

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the company's AGM Presentation held on 15 November 2016.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders

🕔11/15/2016 11:50:40 AM 2022

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the company's latest Chairman's Address to Shareholders at 2016 AGM.

Read Full Article
###

7,251 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 82) (Last 30 Days: 422) (Since Published: 7251) 

Markets ASX:ANR

Company Data

    Headquarters
  • 433 Logan Road, Stones Corner
    Brisbane, Queensland 4120
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports

Presentations

Research Report

Social Media